[Efficacy and tolerance of a new sustained-release preparation of nicotinic alcohol for reduction of the atherosclerotic risk index]

MeSH terms

• Adult
• Aged
• Arteriosclerosis / prevention & control*
• Delayed-Action Preparations
• Female
• Humans
• Hyperlipoproteinemias / complications
• Hyperlipoproteinemias / drug therapy*
• Hypertension / complications
• Male
• Middle Aged
• Nicotinyl Alcohol / administration & dosage
• Nicotinyl Alcohol / therapeutic use*
• Pyridines / therapeutic use*
• Risk